Jesteś tutaj

Recruiting Trials: Cord Blood

This portal enables our readers to find registered clinical trials worldwide that are currently recruiting patients for therapy with cord blood stem cells. If you are a patient seeking more information about a trial, please click on the link under the trial's registry identification. That will take you to the original trial registration, and within that description you should find contact information. This list does not constitute medical advice and Parent's Guide to Cord Blood Foundation has no relationship with any of these trial sponsors. We maintain this list by checking multiple national clinical trial registries. We only display clinical studies that are registered on an official trials registry.

Contents are current through the end of 2021.

This web page was researched by Frances Verter, PhD, Alexey Bersenev, MD PhD, and Pedro Silva Couto, PhD ©2016-2022. Sources of clinical trials were searches of ClinicalTrials.gov, Chinese Clinical Trial Registry (ChiCTR), Japan University hospital Medical Information Network Clinical Trial Registry (UMIN-CTR), Japan Medical Association Clinical Trial Registry (JMA-CTR), Clinical Research Information Service from South Korea (CRiS), EU Clinical Trials Register (EudraCT), World Health Organization International Clinical Trials Registry Platform (ICTRP), Netherlands Trial Register (NTR), Australian New Zealand Clinical Trial Registry (ANZCTR), Clinical Trials Registry-India (CTRI), German Clinical Trials Register (DRKS), and Iranian Registry of Clinical Trials (IRCT).

Displaying 5 clinical trials recruiting at 6 locations.

Autism, or autism spectrum disorder, refers to a range of conditions characterized by challenges with social skills, speech, and repetitive behaviors. Autism is usually diagnosed between 2 and 3 years of age; as of 2021 autism impacts 1 in 44 children in the United States according to the CDC.Clinical trials have explored cell therapy for autism, using either cord blood or cord tissue. Some of the children that have benefited from cord blood therapy are Nicoloz, Levi, and Maksim. Therapy with cells from cord tissue have helped Gage.

Trial registry Patient Ages Hospital Name
up to 18 Duke University Medical Center
up to 18 MD Anderson Cancer Center
3 to 7 Spitalul Angiomedica
3 to 15 Samara Regional Medical Center Dynasty
18 mos to 12 yrs Safra Children's Hospital, Sheba Medical Center
2+ Guangdong Women and Children Hospital